Date: 4.1.2012
A new research study published in the January 2012 edition of The FASEB Journal describes findings that could lead to a non-invasive test that would let expecting mothers know the sex of their baby as early as the first trimester. Specifically, researchers from South Korea discovered that various ratios of two enzymes (DYS14/GAPDH), which can be extracted from a pregnant mother's blood, indicate if the baby will be a boy or a girl. Such a test would be the first of its kind.
Generally, early fetal gender determination has been performed by invasive procedures such as chorionic villus sampling or amniocentesis. However, these invasive procedures still carry a one to two percent risk of miscarriage and cannot be performed until 11 weeks of gestation.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology - Biotechnology channel at Nature.com
ScienceWeek - Biotechnology Science since 1997
Deadly bacteria show thirst for human blood: Research outlines the phenomenon of bacterial vampirism
Rice bran nanoparticles show promise as affordable and targeted anticancer agent